Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to GT199400089ApriorityCriticalpatent/GT199400089A/en
Publication of GT199400089ApublicationCriticalpatent/GT199400089A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
EN FORMA MAS PARTICULAR, LA INVENCION SE REFIERE A FORMAS FISICAS PARTICULARES DEL ACIDO 5ACETMIDO2,3,4,5TETRADESOXI4GUANIDINO DE DANADGLICERODGALACTONON2ENOPIRANOSONICO(EL ANALOGO DE 4 GUANIDINO DE DANA;TAMBIEN CONOCIDO COMOACIDO5(ACETILAMINO)2,6ANHIDRO3,4,5,TRIDESOXI4GUANIDINODGLICERODGALACTONON2ENONICO),FORMULACIONES FARMACEUTICAS DEL MISMO Y SU USO EN LA TERAPIA.IN More particularly, the invention relates to physical forms SPECIFIC ACID 5ACETMIDO2,3,4,5TETRADESOXI4GUANIDINO OF DANADGLICERODGALACTONON2ENOPIRANOSONICO (4 guanidino analogue of DANA; ALSO KNOWN COMOACIDO5 (acetylamino) 2,6ANHIDRO3,4,5, TRIDESOXI4GUANIDINODGLICERODGALACTONON2ENONICO) PHARMACEUTICAL FORMULATIONS OF THE SAME AND ITS USE IN THERAPY.
GT199400089A1994-12-191994-12-19
CRYSTALLINE DERIVATIVES OF N-ACETYL NEURAMIC ACID AND PROCESSES FOR ITS PREPARATION
GT199400089A
(en)
PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS INCORPORATING AS ACTIVE INGREDIENT ISOXAZOL-4-CARBOXYLAMIDE AND HYDROXYLYLIDENE-CYANOOCETAMIDE
1ALFA, 26 DIHIDROXI-D-HOMO-VITAMIN D3, A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, A PROCEDURE FOR ITS PREPARATION AND USE OF THEM IN THE ELABORATION OF A MEDICINAL PRODUCT
COMPOSITIONS INCLUDING AMOXICILLIN AND CLAVULANATE, PROCEDURES FOR ITS PREPARATION AND THE USE OF COMPOSITIONS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
DERIVED FROM THE 3-ARIL-2-HYDROXIPROPIONIC ACID, PROCESS AND INTERMEDIARY FOR THEIR PREPARATION, PHARMACEUTICAL FORMULATIONS, USE OF SUCH COMPOUND IN THE PREPARATION OF A MEDICINAL PRODUCT, METHOD FOR THE PROPHYLAXIS AND / OR TREATMENT OF CLINIC ASSOCIATED RESISTANCES AND FORMULATION